We narrowed to 14,604 results for: RON

#125712-AAVrg

Ready-to-use AAV Retrograde particles produced from pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (#125712). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE plasmid DNA. CaMKIIa-driven expression of the optimized mosquito OPN3 rhodopsin in-frame with mScarlet. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

Ofer Yizhar

Mahn et al Neuron. 2021 May 10. pii: S0896-6273(21)

Jan. 8, 2025

Academic Institutions and Nonprofits only

#213939-AAV1

Ready-to-use AAV1 particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Sept. 23, 2025

Academic Institutions and Nonprofits only

#213945-AAV1

Ready-to-use AAV1 particles produced from pAAV_BiSSTe4_ChR2_mCherry (#213945). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the SST interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Sept. 23, 2025

Academic Institutions and Nonprofits only

#213856-AAV1

Ready-to-use AAV1 particles produced from pAAV_BiVIPe4_ChR2_mCherry (#213856). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the VIP interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Sept. 23, 2025

Academic Institutions and Nonprofits only

#213915-PHPeB

Ready-to-use AAV PHP.eB particles produced from pAAV_BiLAMP5e3_ChR2_mCherry (#213915). In addition to the viral particles, you will also receive purified pAAV_BiLAMP5e3_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the Lamp5 interneuron-targeting enhancer E3. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Dec. 2, 2024

Academic Institutions and Nonprofits only

#111069-AAV1

Ready-to-use AAV1 particles produced from pAAV-CAG-dLight1.2 (#111069). In addition to the viral particles, you will also receive purified pAAV-CAG-dLight1.2 plasmid DNA. CAG-driven expression of dLight1.2 dopamine sensor. These AAV preparations are suitable purity for injection into animals.

Lin Tian

Patriarchi et al Science. 2018 Jun 29;360(6396). pii: sci

Feb. 14, 2022

Academic Institutions and Nonprofits only

#175274-AAV1

Ready-to-use AAV1 particles produced from pAAV-rtTA (#175274). In addition to the viral particles, you will also receive purified pAAV-rtTA plasmid DNA. Syn-driven expression of reverse tetracycline-controlled transactivator. These AAV preparations are suitable purity for injection into animals.

Wei Xu

Li et al Nat Methods. 2021 Nov 25. pii: 10.1038/s

Jan. 15, 2026

Academic Institutions and Nonprofits only

#52711

KIlac with G794A mutation in lacZ (impairs function)

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Feb. 3, 2015

Academic Institutions and Nonprofits only

#52710

KIlac with G794D mutation in lacZ (impairs function)

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Feb. 3, 2015

Academic Institutions and Nonprofits only

#52712

KIlac with W999F mutation in lacZ (impairs function)

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Feb. 2, 2015

Academic Institutions and Nonprofits only

#52713

KIlac with W999L mutation in lacZ (impairs function)

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Feb. 2, 2015

Academic Institutions and Nonprofits only

#52705

KIlac with lacZ C-terminal sssA degradation tag

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Aug. 19, 2014

Academic Institutions and Nonprofits only

#52697

KIlac with a codon optimized lacZ using preferred codon at every position

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Aug. 19, 2014

Academic Institutions and Nonprofits only

#52699

KIlac with a codon optimized lacZ using codons for a subset of amino acids read by transfer RNAs that are the most highly charged during amino acid starvation

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Aug. 19, 2014

Academic Institutions and Nonprofits only

#52701

KIlac with first 37 bases from Oplac1

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Aug. 19, 2014

Academic Institutions and Nonprofits only

#52702

KIlac with first 37 bases from Oplac2

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Aug. 19, 2014

Academic Institutions and Nonprofits only

#52703

Oplac1 with first 37 bases from KIlac

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Aug. 19, 2014

Academic Institutions and Nonprofits only

#52704

Oplac2 with first 37 bases from KIlac

Tanja Kortemme

Eames et al Science. 2012 May 18;336(6083):911-5. do

Aug. 19, 2014

Academic Institutions and Nonprofits only

#58892-AAV5

Ready-to-use AAV5 particles produced from pAAV-GFAP104-ChR2-mCherry (#58892). In addition to the viral particles, you will also receive purified pAAV-GFAP104-ChR2-mCherry plasmid DNA. GFAP -driven, expression of humanized ChR2 H134R mutant fused to mCherry, for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

Edward Boyden

Perea et al Nat Commun. 2014;5:3262. doi: 10.1038/nc

Jan. 14, 2026

Academic Institutions and Nonprofits only

#37984

Han Lim

Lim et al Proc Natl Acad Sci U S A. 2011 Jun 28;10

July 5, 2012

Academic Institutions and Nonprofits only